glp-1 receptor agonists weight loss effectiveness November Blog Reported weight-loss outcomes associated with

Psoriatic arthritis and metabolic syndrome: Is there a role for disease modifying anti-rheumatic drugs

We acknowledge that the inclusion of only four studies in the quantitative synthesis limits the statistical power of our subgroup analyses, particularly when examining outcomes over multiple time points (3, 6, 12, and 24 months)

Obesity and T2DM have both been associated with more aggressive breast cancer and poorer outcomes which has placed metabolic health under closer scrutiny in oncology research

however, it requires self-administration via syringe , increasing complexity and risk of dosing errors

2021;70:673-P

The DHSC issued a national patient safety alert for GLP-1 RAs on 2 January 2024, which stated that the shortage resulted from increased demand for both licensed and off-label indications